Our work observed the serum levels of Slit2 in ApcMin/+ mice at the proliferative stage, adenoma stage, and carcinoma stage, and found that the concentration of Slit2 was increased in the serum of all development stages compared with that in wildtype mice. The gene discussed is SLIT2; the disease is carcinoma.